The Assessment of Using Plasma HBV DNA level as A Prognostic Marker on HCC Patients After Resection
碩士 === 國立彰化師範大學 === 生物學系 === 98 === Abstract Background: Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumor around the world, and has significant distribution difference. Taiwan located on the southeast Asia, a HCC high risk area, and there are many people died from HCC each...
Main Author: | 鄭光洪 |
---|---|
Other Authors: | 簡一治 |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/63518142073551584321 |
Similar Items
-
The Pre- and Postoperative FIB-4 Indexes Are Good Predictors to the Outcomes of HBV-Related HCC Patients after Resection
by: Meng-Yun Tsai, et al.
Published: (2019-01-01) -
Insights of HBV Pathogenesis and Emerging Clinical Therapies for HBV Induced HCC Patients for a Better Prognostic Outcome
by: Reshmi Chatterjee
Published: (2015-02-01) -
Occult HBV infection and HCC
by: Isabelle Chemin
Published: (2007-02-01) -
Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients
by: Mai R, et al.
Published: (2019-10-01) -
Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma
by: Xiao-Meng Dai, et al.
Published: (2017-01-01)